A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
28 May 2021	Submitted	Original manuscript
4 Jun 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
7 Jun 2021	Editorially accepted
15 Jul 2021	Article published	10.1186/s13063-021-05361-y

Back to article page